Generation Bio Co. (GBIO) Insider Trading Activity

NASDAQ$5.34
Market Cap
$35.98M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
—
Rank in Industry
—

GBIO Insider Trading Activity

GBIO Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$
–
Sells
$
–

Related Transactions

About Generation Bio Co.

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Insider Activity of Generation Bio Co.

Over the last 12 months, insiders at Generation Bio Co. have bought $undefined and sold $undefined worth of Generation Bio Co. stock.

On average, over the past 5 years, insiders at Generation Bio Co. have bought $340,126 and sold $16.72M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 85,000 shares for transaction amount of $82,450 was made by Quinn Anthony G. (director) on 2025‑01‑13.

List of Insider Buy and Sell Transactions, Generation Bio Co.

2025-01-13Purchase
Quinn Anthony G.
director
85,000
0.1322%
$0.97
$82,450
-42.17%
2025-01-10Purchase
Quinn Anthony G.
director
125,791
0.1948%
$0.96
$120,759
-42.59%
2024-07-01Sale
Paone Antoinette
CHIEF OPERATING OFFICER
6,719
0.0099%
$2.74
$18,410
-58.17%
2024-01-02Sale
Samayoa Phillip
CHIEF STRATEGY OFFICER
2,445
0.0032%
$1.62
$3,961
+34.14%
2024-01-02Sale
Paone Antoinette
CHIEF OPERATING OFFICER
2,445
0.0032%
$1.62
$3,961
+34.14%
2023-12-08Purchase
Appelhans Dannielle
director
8,000
0.0127%
$1.79
$14,339
+46.49%
2023-12-04Purchase
Rowland Charles A Jr
director
150,000
0.2255%
$1.50
$225,000
+65.23%
2023-12-04Purchase
Appelhans Dannielle
director
12,000
0.018%
$1.50
$18,000
+65.23%
2023-12-01Purchase
Rowland Charles A Jr
director
192,960
0.2723%
$1.31
$252,778
+80.22%
2023-12-01Purchase
Nicholson Donald William
director
100,000
0.1551%
$1.44
$144,000
+80.22%
2023-12-01Purchase
Quinn Anthony G.
director
88,495
0.1344%
$1.41
$124,778
+80.22%
2023-08-23Sale
Paone Antoinette
CHIEF OPERATING OFFICER
3,116
0.0046%
$4.93
$15,362
-44.22%
2023-07-03Sale
Samayoa Phillip
CHIEF STRATEGY OFFICER
3,116
0.0054%
$5.29
$16,484
-41.19%
2023-04-25Sale
Paone Antoinette
CHIEF OPERATING OFFICER
2,914
0.0049%
$4.61
$13,434
-27.77%
2023-01-26Sale
Paone Antoinette
CHIEF OPERATING OFFICER
2,695
0.0044%
$5.56
$14,984
-26.23%
2023-01-10Sale
Paone Antoinette
CHIEF OPERATING OFFICER
1,865
0.003%
$4.57
$8,523
-8.80%
2023-01-09Sale
Samayoa Phillip
CHIEF STRATEGY OFFICER
1,865
0.0035%
$5.11
$9,530
-6.05%
2022-10-27Sale
Paone Antoinette
CHIEF OPERATING OFFICER
2,914
0.0051%
$5.03
$14,657
-5.45%
2022-09-29Sale
Paone Antoinette
CHIEF OPERATING OFFICER
2,828
0.0049%
$5.24
$14,819
-5.30%
2022-03-09Purchase
Nicholson Donald William
8,126
0.0137%
$4.71
$38,273
+14.72%
Total: 96

GBIO Institutional Investors: Active Positions

Increased Positions00%00%
Decreased Positions00%00%
New Positions0New0New
Sold Out Positions0Sold Out0Sold Out
Total Postitions00%00%

GBIO Ownership Change vs Market

No data is available at this moment.

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Atlas Venture Life Science Advisors, Llc$4,508.0011.83%827,946-20%2025-09-30
Price T Rowe Associates Inc /Md/$3,141.008.24%576,789-269,472-31.84%2025-09-30
Renaissance Technologies Llc$1,875.004.92%344,263+86,185+33.4%2025-09-30
Siren, L.L.C.$1,617.004.24%296,892<10%2025-09-30
Vanguard Group Inc$1,251.003.28%229,833-2<0.01%2025-09-30
Marshall Wace, Llp$1,190.003.12%218,461+102,260+88%2025-09-30
Baker Bros. Advisors Lp$1,059.002.78%194,493-2<0.01%2025-09-30
Morgan Stanley$894.002.35%164,270+72,987+79.96%2025-09-30
Ubs Group Ag$810.002.13%148,721+60,231+68.06%2025-09-30
Acadian Asset Management Llc$694.001.82%127,506+4,159+3.37%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.